Currentpremera-bluecrossPolicy 1.01.508

Upcoming Policies for Review

A bulletin listing existing insurer medical policies scheduled for review and soliciting stakeholder feedback by March 5, 2026. It enumerates policy numbers and titles across multiple clinical and procedural areas but does not change coverage positions.

Policy Summary

Payerpremera-bluecross

PolicyUpcoming Policies for Review

Policy CodePolicy 1.01.508

Change TypeReview solicitation (no coverage changes)

Effective DateMar 5, 2026

Next Review Date

Key ActionProviders and stakeholders should submit feedback on any listed policy by March 5, 2026 via email; feedback may inform future policy review.

SourceLink

POLICY UPDATE CHANGES

List of policies scheduled for review and feedback request with deadline March 5, 2026.

45Policies Listed for Review

2026-03-05Feedback Deadline

Summary of Bulletin

This bulletin from the payer lists existing medical policies that are scheduled for review and invites stakeholder feedback by March 5, 2026. It is an informational solicitation and does not make any coverage or coding changes at this time.

No coverage positions are being changed in this bulletin; it simply enumerates policies across multiple clinical areas for potential future review.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Policies Scheduled for Review

Policy Number	Policy Title
1.01.508	Negative Pressure Wound Therapy in the Outpatient Setting
1.01.528	Hearing Aids (Excludes Implantable Devices)
2.01.57	Electrostimulation and Electromagnetic Therapy for Treating Wounds
2.01.107	Fractional Carbon Dioxide (CO2) Laser Ablation Treatment of Hypertrophic Scars or Keloids for Functional Improvement
2.01.543	Recombinant and Autologous Platelet-Derived Growth Factors for Wound Healing and Other Non-Orthopedic Conditions
2.04.136	Nutrient/Nutritional Panel Testing
2.04.509	Cardiovascular Risk Panels
2.04.524	Fecal Analysis in the Diagnosis of Intestinal Dysbiosis
2.04.525	Intracellular Micronutrient Testing
7.01.63	Deep Brain Stimulation
7.01.97	Intracoronary Drug Delivery Balloon Procedures
7.01.153	Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast
7.01.174	Stationary Ultrasonic Diathermy Devices
7.01.176	Suture Button Suspensionplasty Fixation System for Thumb Carpometacarpal Osteoarthritis
7.01.508	Blepharoplasty, Blepharoptosis and Brow Ptosis Surgery
7.01.516	Bariatric Surgery
7.01.523	Panniculectomy and Excision of Redundant Skin
7.01.533	Reconstructive Breast Surgery/Management of Breast Implants
7.01.550	Knee Arthroplasty in Adults
7.01.557	Gender Transition/Affirmation Surgery and Related Services
7.01.558	Rhinoplasty
7.01.563	Ablative Treatments for Occipital Neuralgia, Chronic Headaches, and Atypical Facial Pain
7.01.564	Pulsed Radiofrequency for the Treatment of Chronic Pain
7.01.573	Hip Arthroplasty in Adults
7.01.589	Artificial Intervertebral Disc: Lumbar Spine
7.01.590	Shoulder Arthroplasty
8.01.15	Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
8.01.17	Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome
8.01.23	Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer
8.01.24	Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
8.01.25	Hematopoietic Cell Transplantation for Autoimmune Diseases
8.01.26	Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
8.01.28	Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and Ependymoma
8.01.30	Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
8.01.36	Extracorporeal Photopheresis
8.01.42	Hematopoietic Cell Transplantation for Primary Amyloidosis
8.01.52	Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used with Autologous Bone Marrow)
8.01.55	Stem Cell Therapy for Peripheral Arterial Disease
8.01.520	Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
8.01.529	Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas
8.01.532	Hematopoietic Cell Transplantation in the Treatment of Germ-Cell Tumors
8.01.539	Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms
8.03.502	Physical Medicine and Rehabilitation - Physical Therapy and Medical Massage Therapy
8.03.503	Occupational Therapy
8.03.505	Speech Therapy

What Providers & Stakeholders Should Do

Documentation Required

Submit feedback

Providers and stakeholders are invited to submit feedback on any listed policy by March 5, 2026 via email. Feedback may be considered in future policy review.

Deadline: 2026-03-05
How to submit: email (provide contact method placeholder)

This bulletin is informational and does not change current coverage positions or coding; no material changes are being proposed in this announcement.

Scope & Contact

Background: The bulletin lists existing insurer medical policies scheduled for review and solicits feedback from providers and stakeholders by March 5, 2026. The enumerated policies span areas including wound care, diagnostic testing and imaging, surgical procedures, transplantation and hematologic therapies, rehabilitation services, and other clinical and procedural topics.

No material changes are proposed in this bulletin; it is a request for comments that may inform future policy review rather than an immediate modification of coverage criteria or coding.

Feedback Deadline2026-03-05

PayerPremera Blue Cross

Document StatusCURRENT

Effective Date2026-03-05

Number of Policies Listed45

OpenPayer

Upcoming Policies for Review

Summary of Bulletin

Policies Scheduled for Review

What Providers & Stakeholders Should Do

Document Changes & Key Dates

Scope & Contact